+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 2066-89-9
2066-89-9,MFCD00079376
Catalog No.:AA0072O3

2066-89-9 | Pasiniazid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$6.00   $4.00
- +
100mg
98%
in stock  
$18.00   $13.00
- +
1g
98%
in stock  
$75.00   $53.00
- +
5g
98%
in stock  
$99.00   $69.00
- +
10g
98%
in stock  
$120.00   $84.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0072O3
Chemical Name:
Pasiniazid
CAS Number:
2066-89-9
Molecular Formula:
C13H14N4O4
Molecular Weight:
290.2747
MDL Number:
MFCD00079376
SMILES:
Nc1ccc(c(c1)O)C(=O)O.NNC(=O)c1ccncc1
NSC Number:
758447
Properties
Computed Properties
 
Complexity:
280  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
5  
Rotatable Bond Count:
2  

Downstream Synthesis Route

[1]Locationinpatent:experimentalpartGrobelny,Pawel;Mukherjee,Arijit;Desiraju,GautamR.[CrystEngComm,2011,vol.13,#13,p.4358-4364]

[2]Li,Zhen;Wang,Yude;Chen,Sheng;Li,Linwei;Sun,Tiemin[JournalofMolecularStructure,2017,vol.1133,p.179-186]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: [Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].

Journal: Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040501

Title: [Clinical research of pasinizid on retreated sputum positive pulmonary tuberculosis in senilities].

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20011001

Title: A comparison of isoniazid-cycloserine with isoniazid-PAS in the therapy of cavitary pulmonary tuberculosis. X. A report of the Veterans Administration-Armed Forces cooperative study.

Journal: The American review of respiratory disease 19600601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 2066-89-9
Building Blocks
More >
Tags:2066-89-9 Molecular Formula|2066-89-9 MDL|2066-89-9 SMILES|2066-89-9 Pasiniazid